These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 38481996)

  • 1. Serum high mobility group box 1 as a potential biomarker for the progression of kidney disease in patients with type 2 diabetes.
    Liu T; Zhao H; Wang Y; Qu P; Wang Y; Wu X; Zhao T; Yang L; Mao H; Peng L; Zhan Y; Li P
    Front Immunol; 2024; 15():1334109. PubMed ID: 38481996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of UbA52 level in the urine of patients with type 2 diabetes mellitus and diabetic kidney disease.
    Xu X; Dong Y; Liu M; Li Y; Zhang Y
    Nefrologia (Engl Ed); 2021; 41(5):548-555. PubMed ID: 36165137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of serum cathepsin S in type 2 diabetic kidney disease.
    Ren X; Wang W; Cao H; Shao F
    Front Endocrinol (Lausanne); 2023; 14():1180338. PubMed ID: 37305031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Human Epididymis Protein 4 is Associated with Renal Function and Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus.
    Zhang M; Zhao B; Xie J; Liang Y; Yang Z
    Biomed Res Int; 2019; 2019():4831459. PubMed ID: 31815140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and internal validation of machine learning algorithms for end-stage renal disease risk prediction model of people with type 2 diabetes mellitus and diabetic kidney disease.
    Zou Y; Zhao L; Zhang J; Wang Y; Wu Y; Ren H; Wang T; Zhang R; Wang J; Zhao Y; Qin C; Xu H; Li L; Chai Z; Cooper ME; Tong N; Liu F
    Ren Fail; 2022 Dec; 44(1):562-570. PubMed ID: 35373711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Glomerular Complement C4c Deposition With the Progression of Diabetic Kidney Disease in Patients With Type 2 Diabetes.
    Duan S; Sun L; Nie G; Chen J; Zhang C; Zhu H; Huang Z; Qian J; Zhao X; Xing C; Zhang B; Yuan Y
    Front Immunol; 2020; 11():2073. PubMed ID: 32983156
    [No Abstract]   [Full Text] [Related]  

  • 7. Impaired Amino Acid Metabolism and Its Correlation with Diabetic Kidney Disease Progression in Type 2 Diabetes Mellitus.
    Zhu H; Bai M; Xie X; Wang J; Weng C; Dai H; Chen J; Han F; Lin W
    Nutrients; 2022 Aug; 14(16):. PubMed ID: 36014850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma Biomarkers and Kidney Function Decline in Early and Established Diabetic Kidney Disease.
    Coca SG; Nadkarni GN; Huang Y; Moledina DG; Rao V; Zhang J; Ferket B; Crowley ST; Fried LF; Parikh CR
    J Am Soc Nephrol; 2017 Sep; 28(9):2786-2793. PubMed ID: 28476763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic immune-inflammation index is associated with diabetic kidney disease in Type 2 diabetes mellitus patients: Evidence from NHANES 2011-2018.
    Guo W; Song Y; Sun Y; Du H; Cai Y; You Q; Fu H; Shao L
    Front Endocrinol (Lausanne); 2022; 13():1071465. PubMed ID: 36561561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of urinary NGAL for differential diagnosis and progression of diabetic kidney disease.
    Duan S; Chen J; Wu L; Nie G; Sun L; Zhang C; Huang Z; Xing C; Zhang B; Yuan Y
    J Diabetes Complications; 2020 Oct; 34(10):107665. PubMed ID: 32653382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum and Urinary Progranulin in Diabetic Kidney Disease.
    Nicoletto BB; Krolikowski TC; Crispim D; Canani LH
    PLoS One; 2016; 11(10):e0165177. PubMed ID: 27776152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low Serum Dehydroepiandrosterone Is Associated With Diabetic Kidney Disease in Men With Type 2 Diabetes Mellitus.
    Zhang X; Xiao J; Li X; Cui J; Wang K; He Q; Liu M
    Front Endocrinol (Lausanne); 2022; 13():915494. PubMed ID: 35784547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of urinary acidification function with the progression of diabetic kidney disease in patients with type 2 diabetes.
    Zhu H; Liu X; Zhang C; Li Q; An X; Liu S; Wu L; Zhang B; Yuan Y; Xing C
    J Diabetes Complications; 2019 Nov; 33(11):107419. PubMed ID: 31473080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytosolic Hmgb1 accumulation in mesangial cells aggravates diabetic kidney disease progression via NFκB signaling pathway.
    Wu K; Zha H; Wu T; Liu H; Peng R; Lin Z; Lv D; Liao X; Sun Y; Zhang Z
    Cell Mol Life Sci; 2024 Sep; 81(1):408. PubMed ID: 39287634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications of increased circulating macrophage inhibitory protein-5 in patients with type 2 diabetes mellitus.
    Zhao B; Zhang M; Xie J; Jiang T; Li J; Yang Z
    Int Immunopharmacol; 2022 Aug; 109():108916. PubMed ID: 35679662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 12(S)-hydroxyeicosatetraenoic acid is significantly increased in diabetic kidney disease and associated with renal function decline.
    Xu J; Jin L; Sun Y; Zhang R; Chen X; Zhou R; Gu Y; Hu C
    Diabetes Metab Res Rev; 2022 Sep; 38(6):e3554. PubMed ID: 35667014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular status of thrombospondin-2 in type 2 diabetes mellitus and utility as a biomarker in the determination of early diabetic kidney disease.
    Lin Z; Zhang D; Zhang X; Guo W; Wang W; Zhang Y; Liu Z; Bi Y; Wu M; Lin Z; Lu X
    BMC Nephrol; 2023 May; 24(1):154. PubMed ID: 37259071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous detection of multiple urinary biomarkers in patients with early-stage diabetic kidney disease using Luminex liquid suspension chip technology.
    Li X; Zhang X; Wang S; Li Y; Meng C; Wang J; Chang B; Yang J
    Front Endocrinol (Lausanne); 2024; 15():1443573. PubMed ID: 39229378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of the natural history of diabetic kidney disease (DKD).
    Altemtam N; Russell J; El Nahas M
    Nephrol Dial Transplant; 2012 May; 27(5):1847-54. PubMed ID: 22058177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum lutein is a promising biomarker for type 2 diabetes mellitus and diabetic kidney disease in the elderly.
    Pan F; Cui W; Gao L; Shi X; Yang H; Hu Y; Li M
    J Clin Lab Anal; 2022 Apr; 36(4):e24350. PubMed ID: 35293029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.